4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Cardiovascular Regenerative Medicine
Cardiovascular regenerative medicine is an emerging field focused on repairing and restoring damaged heart tissues using cutting-edge biological approaches. Stem cell therapy has shown promise in regenerating cardiomyocytes and improving heart function in patients with heart failure or myocardial infarction. Researchers are also exploring the potential of tissue engineering to create bioengineered heart patches for targeted repair. Additionally, advancements in gene editing techniques like CRISPR are being investigated to correct genetic mutations associated with cardiovascular disorders. By combining biomaterials, cellular therapies, and innovative delivery systems, cardiovascular regenerative medicine aims to revolutionize treatment outcomes and offer hope to patients suffering from severe cardiac conditions.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Sana Tariq
Manchester University NHS Foundation Trust, United Kingdom
Achi Kamaraj
Royal Brisbane and Women’s Hospital, Austria
Agustin Joison
Cordoba Catholic University, ArgentinaSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom